We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Companies Begin Selling Generic Migraine Drug
Companies Begin Selling Generic Migraine Drug
February 17, 2009
Teva Pharmaceutical Industries now can offer customers all dosages of its generic Imitrex, GlaxoSmithKline’s (GSK) migraine treatment, after final FDA approval.